When you are using compounded semaglutide, that assumption can be dangerously wrong
Dulaglutide Drugs BNF / NICE
Questionable Drug Quality and Regulation The FDA has issued warnings about the dangers of using unapproved versions of weight-loss medications like semaglutide and tirzepatide, citing reports of adverse events affecting hundreds of patients
Common symptoms include fatigue, cold intolerance, constipation, dry skin, and hair loss
However, due to high out-of-pocket costs, drug shortages, and the fact that a prescription is needed to obtain these medications, people might be searching for other options
Understanding the differences between injectable and oral peptide formats and the distinction between research and pharmaceutical grade peptides further informs your sourcing decisions